AVR vs PSA · rev $1.9M vs rev $1.23B
Anteris Technologies Global Corp. Common Stock (AVR) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
PSA (PSA) common stock.
Latest reported AVR revenue for 2025-12-31 was $1.9M. Net income was -$94.1M. Revenue was down 29.2% from 2024-12-31 to 2025-12-31. AVR currently screens at market cap $287.2M.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
AVR currently screens at market cap $287.2M. PSA currently screens at market cap $0.
Not investment advice. Open the AVR and PSA stock pages for the full models.
Not investment advice.